Based on record review, interview, and policy review, the provider failed to ensure one of one sampled resident (49), had her PRN (as needed) psychotropic medication discontinued after 14 days as ordered by the physician. Findings include: 1. Review of resident 49's electronic medical record (EMR) revealed: *A 3/27/25 order for Lorazepam (anti-anxiety/psychotropic medication) 0.5 mg tablet by mouth every six hours PRN for anxiety/agitation/restlessness. -The physician's order note regarding that same medication indicated: If PRN, order stop date=14 days. Review of resident 49's March 2025 and April 2025 medication administration records revealed: *She had not been administered the PRN Lorazepam in either month. …
F758 citations in South Dakota
Psychotropic drugs · Pharmacy Service Deficiencies
Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated, prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic medications are only used when the medication is necessary and PRN use is limited.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
South Dakota cites F758 less often than its own record predicts
0.80 times the national share — cited less often here than elsewhere.
Of every deficiency written in South Dakota in 2025, this is the portion that was F758.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What South Dakota surveyors wrote
F758 findings written in South Dakota, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
The short window
Recent years
| Year | Share of South Dakota citations | vs expected |
|---|---|---|
| 2023 | 2.17% | 1.32× |
| 2024 | 0.45% | 0.30× |
| 2025 | 0.50% | 0.80× |
Shares of citations, not counts: earlier years hold fewer inspections.
What else South Dakota surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction